ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
729.00
-34.00 (-4.46%)
At close: May 29, 2026

KOSDAQ:034940 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8252,3252,0972,0474,5265,749
Short-Term Investments
199.74198.122,5491,5381,5371,587
Trading Asset Securities
--800.73775.022,3862,849
Cash & Short-Term Investments
3,0252,5235,4474,3618,44910,184
Cash Growth
64.35%-53.69%24.93%-48.39%-17.04%12.59%
Accounts Receivable
17,57617,80818,25020,23022,72720,884
Other Receivables
1,9341,6711,8182,5932,7312,359
Receivables
19,92219,92320,94823,90027,60324,867
Inventory
11,72911,71712,44613,01210,86910,286
Prepaid Expenses
-96.25204.8887.4594.42118.8
Other Current Assets
1,035792.76693.01796.441,1831,048
Total Current Assets
35,71135,05239,74042,15748,20046,504
Property, Plant & Equipment
17,35819,06719,71220,37024,99924,074
Long-Term Investments
2,9853,5343,0682,7922,9353,678
Goodwill
-----46.78
Other Intangible Assets
559.42549.56769803.4806.87795.5
Long-Term Accounts Receivable
--01,0541,054-
Long-Term Deferred Tax Assets
365.47365.471,3701,4991,401945.32
Other Long-Term Assets
5,8605,9166,6625,5446,0284,049
Total Assets
63,03964,68371,32074,22185,63980,512
Accounts Payable
3,5963,4864,8655,5014,9943,685
Accrued Expenses
-3,0803,5163,4942,7652,775
Short-Term Debt
20,55022,10520,75014,55014,55412,794
Current Portion of Long-Term Debt
1,409905.51448.61---
Current Portion of Leases
638.25564.54629.07633.15637.5684.07
Current Unearned Revenue
-73.84140.5153.42122.2788.1
Other Current Liabilities
6,7635,5456,3064,8474,2554,236
Total Current Liabilities
32,95635,75936,65629,17827,32824,263
Long-Term Debt
3,0071,9731,5761,1051,9041,000
Long-Term Leases
1,9551,7571,2851,2131,5831,996
Pension & Post-Retirement Benefits
1,6391,4351,301545.82-1,328
Other Long-Term Liabilities
1,8631,9911,9413,4223,4173,542
Total Liabilities
41,42042,91642,75935,46434,23132,129
Common Stock
15,49015,49015,49015,49015,49015,490
Additional Paid-In Capital
63,62163,62163,62163,62163,62163,621
Retained Earnings
-54,154-54,180-47,817-38,175-26,354-29,255
Comprehensive Income & Other
76.4774.0281.6757.0786.2964.05
Total Common Equity
25,03425,00531,37640,99352,84449,920
Minority Interest
-3,415-3,239-2,815-2,235-1,436-1,537
Shareholders' Equity
21,61921,76728,56138,75851,40848,383
Total Liabilities & Equity
63,03964,68371,32074,22185,63980,512
Total Debt
27,55927,30524,68917,50118,67816,474
Net Cash (Debt)
-24,534-24,782-19,242-13,141-10,229-6,289
Net Cash Per Share
-825.00-799.95-621.05-424.17-330.17-203.02
Filing Date Shares Outstanding
26.1430.9830.9830.9830.9830.98
Total Common Shares Outstanding
26.1430.9830.9830.9830.9830.98
Working Capital
2,755-707.593,08412,97920,87222,242
Book Value Per Share
957.71807.151012.781323.221705.751611.38
Tangible Book Value
24,47424,45630,60740,19052,03749,078
Tangible Book Value Per Share
936.31789.41987.961297.291679.701584.20
Land
7,3968,8118,8118,8649,4089,329
Buildings
3,00714,61514,75614,73918,17818,129
Machinery
4,30230,79530,69330,23326,89326,807
Construction In Progress
346.63508.12-7.244,1571,430